IBI-Ag is a biotechnology company developing a new class of bioinsecticides.
IBI-Ag has raised $6.1M in total funding. The most recent round was Series A. The last funding was announced in February 2025.
IBI-Ag's investors include Israel Innovation Authority, Corteva Agriscience, Trendlines Group, Iron Nation, Consensus Business Group.
IBI-Ag is headquartered in Ness Ziona, Israel.
IBI-Ag is a biotechnology company developing a new class of bioinsecticides.
IBI-Ag is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"IBI-Ag — Funding & Investors." VCBacked, February 13, 2025, https://www.vcbacked.co/company/ibi-ag. Accessed July 26, 2026.
VCBacked. (2025). IBI-Ag — Funding & Investors. Retrieved July 26, 2026, from https://www.vcbacked.co/company/ibi-ag
{{cite web |title=IBI-Ag — Funding & Investors |url=https://www.vcbacked.co/company/ibi-ag |website=VCBacked |access-date=July 26, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated